This post was written by Luis Enrique Rosas (Intern at Mexican Supreme Court), summer research assistant at Georgetown University Law Center. Any comments or questions about this post can be directed to email@example.com. The 23rd session of The United Nations Human Rights Council was held in Vienna on May 27-June 14, 2013. In the session, […]
The advent of big data has forced a sea change throughout the scientific research enterprise, shaking the industry’s fundamental attitude towards the data themselves. Data is now understood as the currency of research. Consequently, industry is warming to the new reality that legal norms once considered to drive business – confidential commercial information, trade secrets […]
This post was written by Florian Kastler (Global Health LL.M. 2011), visiting researcher at Georgetown University Law Center. Any comments or questions about this post can be directed to firstname.lastname@example.org. Last week, on 9 July 2013, the World Health Organization (WHO) updated its Questions and answers on electronic cigarettes or electronic nicotine delivery systems (ENDS) […]
This post was written by Holly Jarman, Research Assistant Professor at the University of Michigan. For more information about this post, please contact email@example.com. The original post can be found at the Huffington Post. The government’s disappointing U-turn over plain packaging of tobacco has dealt a blow to campaigners and shows a government attempting to […]
A Georgetown public health expert and attorney examines what the FDA must do to prevail. WASHINGTON — When the U.S. Food and Drug Administration (FDA) imposes new graphic warning labels for tobacco products, they can survive a First Amendment challenge if they depict health consequences and their effectiveness is supported by adequate scientific evidence, says […]
This post was written by Belen Rios, Research Assistant, Global Health LL.M. ‘13, at the O’Neill Institute for National and Global Health Law. Any questions or comments about this post can be directed to firstname.lastname@example.org. A recent study published by the World Health Organization (WHO) has shown that the adoption of tobacco control laws around the […]
This post was written by Mengyi Xu, O’Neill Institute Summer Intern, Princeton University ’14. Any comments or questions about this post can be directed to email@example.com. To regulate or not to regulate, that is always the question. On the opening day of the O’Neill Institute’s Summer Program on NCDs and law, Professor Alberto Alemanno from HEC […]
This post was written by Florian Kastler (Global Health LL.M. 2011), visiting researcher at Georgetown University Law Center. Any comments or questions about this post can be directed to firstname.lastname@example.org. By a decision overriding its own council on Science and Public Health, the house of delegates of the American Medical Association (AMA) has officially recognized […]
In a decision that could save U.S. consumers and taxpayers billions of dollars a year, the Supreme Court ruled Monday that “pay-for-delay,” also known as “reverse payment” settlements, between name-brand and generics pharmaceutical companies are subject to antitrust laws. The seeds of the controversy were planted in 1984 with the passage of the Hatch-Waxman […]
Our 2013 Summer Program on non-communicable diseases (NCDs) is underway! Here’s what our participants have to look forward to on Day 2.
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.